News
Former Google CEO Eric Schmidt said Trump's funding cuts could chill US tech development just as competition with China is ...
Regeneron Pharmaceuticals and Sanofi won U.S. Food and Drug Administration expanded approval of their blockbuster anti-inflammatory drug Dupixent for the inflammatory skin condition chronic ...
The 10-year-old developed kidney failure after eating contaminated lettuce. The source of the outbreak that made 89 people ...
The transformation of Chinese consumption habits is accelerating, with consumers poised to boost spending on leisure, ...
With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...
Evotec is particularly focused on expanding its biologics capabilities to meet increased demand for complex biologics manufacturing and broaden its offerings to customers. We expect the company will ...
1d
Zacks Investment Research on MSNIs iShares Biotechnology ETF (IBB) a Strong ETF Right Now?A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ETFs? The ...
Bioinformatics: Exploiting Biological Data For Patenting In India. Legal News and Analysis - India - Intellectual Property - ...
In a breakthrough with promising real-world applications, a team of Rutgers biophysicists, bioengineers, and plant biologists ...
Crafted Stories on MSN1d
Dire Wolves Brought Back from 13,000-Year ExtinctionColossal Biosciences, a Dallas-based biotechnology firm, has announced the birth of three genetically engineered wolf pups—Romulus, Remus, and Khaleesi—that they claim represent the "de-extinction" of ...
A 1975 meeting at the Asilomar Conference Center in Pacific Grove, California, shaped a new safety regime for recombinant DNA ...
Advancing development of next-generation precision Antibody Drug Conjugates (ADCs) to address multiple indications across a range of cancer types ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results